For the identification of CSCs, several putative markers such as transmembrane glycoprotein (CD133) and the cell-surface glycoprotein (CD44) were reported to be expressed in colorectal cancer and correlated with high-risk cases and a poorer survival rate of colorectal cancer patients [8,9]. This evidence concerns the gene PROM1 and colorectal cancer.